Pharmafile Logo

Cuttsy+Cuttsy’s first EcoVadis rating comes back silver!

Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating

Over the past year we have been making practical steps to align Cuttsy+Cuttsy to a more sustainable future. Earlier this month, we completed our first voluntary assessment as part of this goal. EcoVadis is a sustainability ratings provider who partner with companies to supply a globally recognised scorecard and performance improvement tools. The submission required a thorough audit across many of our operations, processes, and carbon footprint.

The results are in and Cuttsy+Cuttsy now rate among the top 25 percent of companies assessed by EcoVadis, scoring us a Silver accreditation. As our first submission, this is slightly mind-blowing.

To say I am over the moon would be an understatement. The team and I have worked incredibly hard, and our commitment to sustainability has clearly been reflected. We are incredibly proud of this score, and we are already working on the objectives to achieve Gold.

We are firm believers in better health for everyone and this cannot be achieved without also considering the health of our planet. This is just the first voluntary disclosure we have conducted this year, there will be plenty more to come. Watch this space.

Cuttsy+Cuttsy are committed to a net zero future, and we will achieve this through accurate carbon disclosures and verifiable science-based targets. We will accomplish this, and I look forward to the day when we announce ‘WE DID IT’.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

Where it all began – why we developed The Experience Gap

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.